Published in Hepatitis Weekly, October 24th, 2011
"IFN a2 and IFN ß are non redundant in their expression and in their potency to exert specific bioactivities. The more recently identified...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2011-10-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.